Accolade Statistics

Total Valuation

Moderna has a market cap or net worth of EUR 9.25 billion. The enterprise value is 5.41 billion.

Market Cap	9.25B
Enterprise Value	5.41B

Important Dates

The last earnings date was Thursday, July 31, 2025.

Earnings Date	Jul 31, 2025
Ex-Dividend Date	n/a

Share Statistics

Current Share Class	386.74M
Shares Outstanding	n/a
Shares Change (YoY)	+1.05%
Shares Change (QoQ)	+0.52%
Owned by Insiders (%)	n/a
Owned by Institutions (%)	n/a
Float	360.97M

Valuation Ratios

PE Ratio	n/a
Forward PE	n/a
PS Ratio	3.53
PB Ratio	1.16
P/TBV Ratio	1.16
P/FCF Ratio	n/a
P/OCF Ratio	n/a
PEG Ratio	n/a

Financial Ratio History

Enterprise Valuation

EV / Earnings	-2.19
EV / Sales	2.03
EV / EBITDA	n/a
EV / EBIT	n/a
EV / FCF	-1.82

Financial Position

The company has a current ratio of 3.93, with a Debt / Equity ratio of 0.07.

Current Ratio	3.93
Quick Ratio	3.29
Debt / Equity	0.07
Debt / EBITDA	n/a
Debt / FCF	-0.20
Interest Coverage	-136.38

Financial Efficiency

Return on equity (ROE) is -27.50% and return on invested capital (ROIC) is -17.73%.

Return on Equity (ROE)	-27.50%
Return on Assets (ROA)	-14.78%
Return on Invested Capital (ROIC)	-17.73%
Return on Capital Employed (ROCE)	-31.36%
Revenue Per Employee	451,882
Profits Per Employee	-426,190
Employee Count	5,800
Asset Turnover	0.22
Inventory Turnover	18.79

Taxes

Income Tax	-35.76M
Effective Tax Rate	n/a

Stock Price Statistics

The stock price has decreased by -78.67% in the last 52 weeks. The beta is 1.85, so Moderna's price volatility has been higher than the market average.

Beta (5Y)	1.85
52-Week Price Change	-78.67%
50-Day Moving Average	25.25
200-Day Moving Average	32.08
Relative Strength Index (RSI)	38.56
Average Volume (20 Days)	992

Short Selling Information

Short Interest	n/a
Short Previous Month	n/a
Short % of Shares Out	n/a
Short % of Float	n/a
Short Ratio (days to cover)	n/a

Income Statement

In the last 12 months, Moderna had revenue of EUR 2.62 billion and -2.47 billion in losses. Loss per share was -6.41.

Revenue	2.62B
Gross Profit	-2.49B
Operating Income	-2.79B
Pretax Income	-2.51B
Net Income	-2.47B
EBITDA	-2.61B
EBIT	-2.79B
Loss Per Share	-6.41

Full Income Statement

Balance Sheet

The company has 4.37 billion in cash and 594.35 million in debt, giving a net cash position of 3.77 billion.

Cash & Cash Equivalents	4.37B
Total Debt	594.35M
Net Cash	3.77B
Net Cash Per Share	n/a
Equity (Book Value)	8.00B
Book Value Per Share	20.63
Working Capital	3.92B

Full Balance Sheet

Cash Flow

In the last 12 months, operating cash flow was -2.30 billion and capital expenditures -675.24 million, giving a free cash flow of -2.97 billion.

Operating Cash Flow	-2.30B
Capital Expenditures	-675.24M
Free Cash Flow	-2.97B
FCF Per Share	n/a

Full Cash Flow Statement

Margins

Gross margin is -95.09%, with operating and profit margins of -106.34% and -94.31%.

Gross Margin	-95.09%
Operating Margin	-106.34%
Pretax Margin	-95.68%
Profit Margin	-94.31%
EBITDA Margin	-99.58%
EBIT Margin	-106.34%
FCF Margin	n/a

Dividends & Yields

Moderna does not appear to pay any dividends at this time.

Dividend Per Share	n/a
Dividend Yield	n/a
Dividend Growth (YoY)	n/a
Years of Dividend Growth	n/a
Payout Ratio	n/a
Buyback Yield	-1.05%
Shareholder Yield	n/a
Earnings Yield	-26.73%
FCF Yield	-32.14%

Fair Value

There are several formulas that can be used to estimate the intrinsic value of a stock.

Lynch Fair Value	n/a
Lynch Upside	n/a
Graham Number	n/a
Graham Upside	n/a

Stock Splits

This stock does not have any record of stock splits.

Last Split Date	n/a
Split Type	n/a
Split Ratio	n/a

Scores

Altman Z-Score	n/a
Piotroski F-Score	1